MiRus, a Marietta, GA-based commercial stage life sciences company, completed a $65m funding round.
The round was led by Mammoth Scientific and multi-generational family offices who have supported MiRus from its inception.
The company intends to use the funds for growth of its spine and extremity portfolios and development of structural heart disease solutions using its proprietary Rhenium-based alloys (MoRe®).
Led by Jay S. Yadav MD, Founder and CEO, MiRus is a life sciences company that has developed and is commercializing proprietary novel biomaterials, implants and procedural solutions for the treatment of spine, orthopaedic and structural heart disease. The company has broad global patent coverage for all medical implants made from Rhenium-based superalloys. The spine implants are distributed through hospitals and surgery centers around the country.
FinSMEs
27/07/2021